Your browser doesn't support javascript.
loading
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Suzuki, Rigel; Yamasoba, Daichi; Kimura, Izumi; Wang, Lei; Kishimoto, Mai; Ito, Jumpei; Morioka, Yuhei; Nao, Naganori; Nasser, Hesham; Uriu, Keiya; Kosugi, Yusuke; Tsuda, Masumi; Orba, Yasuko; Sasaki, Michihito; Shimizu, Ryo; Kawabata, Ryoko; Yoshimatsu, Kumiko; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Sawa, Hirofumi; Ikeda, Terumasa; Irie, Takashi; Matsuno, Keita; Tanaka, Shinya; Fukuhara, Takasuke; Sato, Kei.
Afiliação
  • Suzuki R; Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Yamasoba D; Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kimura I; Faculty of Medicine, Kobe University, Kobe, Japan.
  • Wang L; Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kishimoto M; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Ito J; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Morioka Y; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Nao N; Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nasser H; Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Uriu K; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Kosugi Y; One Health Research Center, Hokkaido University, Sapporo, Japan.
  • Tsuda M; Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan.
  • Orba Y; Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
  • Sasaki M; Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Shimizu R; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kawabata R; Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Yoshimatsu K; Laboratory of Systems Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Asakura H; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
  • Nagashima M; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Sadamasu K; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Yoshimura K; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Sawa H; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Ikeda T; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Irie T; Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan.
  • Matsuno K; Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Tanaka S; Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
  • Fukuhara T; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Sato K; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Nature ; 603(7902): 700-705, 2022 03.
Article em En | MEDLINE | ID: mdl-35104835
ABSTRACT
The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern1. In this study, our statistical modelling suggests that Omicron has spread more rapidly than the Delta variant in several countries including South Africa. Cell culture experiments showed Omicron to be less fusogenic than Delta and than an ancestral strain of SARS-CoV-2. Although the spike (S) protein of Delta is efficiently cleaved into two subunits, which facilitates cell-cell fusion2,3, the Omicron S protein was less efficiently cleaved compared to the S proteins of Delta and ancestral SARS-CoV-2. Furthermore, in a hamster model, Omicron showed decreased lung infectivity and was less pathogenic compared to Delta and ancestral SARS-CoV-2. Our multiscale investigations reveal the virological characteristics of Omicron, including rapid growth in the human population, lower fusogenicity and attenuated pathogenicity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Internalização do Vírus / SARS-CoV-2 / COVID-19 / Fusão de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Internalização do Vírus / SARS-CoV-2 / COVID-19 / Fusão de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article